Current News

SFA Therapeutics Announces FDA Approval To Begin Clinical Trial To Treat Symptoms Of Psoriasis

By Nour Obeidallah June 30, 2020 No Comments

SFA Therapeutics Announces FDA Approval To Begin Clinical Trial To Treat Symptoms Of Psoriasis

Next PostJacob Becraft, CEO of Strand Therapeutics, Explains How We Can Build Better Pandemic Response Technologies And Become A "Post-Pandemic Species"